Literature DB >> 20159899

Prophylaxis of migraine headache.

Tamara Pringsheim1, W Jeptha Davenport, Werner J Becker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20159899      PMCID： PMC2855933          DOI： 10.1503/cmaj.081657

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  79 in total

1.  Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  S D Silberstein
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

2.  Long-term results of migraine prophylaxis with flunarizine and beta-blockers.

Authors:  C Wöber; C Wöber-Bingöl; G Koch; P Wessely
Journal:  Cephalalgia       Date:  1991-12       Impact factor: 6.292

3.  Comparison of the effect of topiramate and sodium valporate in migraine prevention: a randomized blinded crossover study.

Authors:  Vahid Shaygannejad; Mohsen Janghorbani; Abbas Ghorbani; Fereshteh Ashtary; Naser Zakizade; Vida Nasr
Journal:  Headache       Date:  2006-04       Impact factor: 5.887

4.  Low-dose topiramate versus lamotrigine in migraine prophylaxis (the Lotolamp study).

Authors:  Praveen Gupta; Sumit Singh; Vinay Goyal; Garima Shukla; Madhuri Behari
Journal:  Headache       Date:  2007-03       Impact factor: 5.887

5.  Botulinum toxin type A in prophylactic treatment of migraine.

Authors:  K S Anand; Atul Prasad; M M Singh; Sangeeta Sharma; Kiran Bala
Journal:  Am J Ther       Date:  2006 May-Jun       Impact factor: 2.688

6.  A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis.

Authors:  P O Osterman
Journal:  Acta Neurol Scand       Date:  1977-07       Impact factor: 3.209

7.  A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial.

Authors:  Morris Maizels; Andrew Blumenfeld; Raoul Burchette
Journal:  Headache       Date:  2004-10       Impact factor: 5.887

8.  A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis.

Authors:  Frederick G Freitag; S D Collins; H A Carlson; J Goldstein; J Saper; S Silberstein; N Mathew; P K Winner; R Deaton; K Sommerville
Journal:  Neurology       Date:  2002-06-11       Impact factor: 9.910

9.  Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Authors:  Sheena K Aurora; Marek Gawel; Jan L Brandes; Suriani Pokta; Amanda M Vandenburgh
Journal:  Headache       Date:  2007-04       Impact factor: 5.887

10.  Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.

Authors:  H-C Diener; G Bussone; J C Van Oene; M Lahaye; S Schwalen; P J Goadsby
Journal:  Cephalalgia       Date:  2007-04-18       Impact factor: 6.292
View more
  12 in total

1.  Capsule Commentary on Jackson et al., Tricyclic and Tetracyclic Antidepressants for the Prevention of Frequent Episodic or Chronic Tension-Type Headache in Adults: A Systematic Review and Meta-Analysis.

Authors:  Akira Kuriyama
Journal:  J Gen Intern Med       Date:  2017-12       Impact factor: 5.128

2.  A 32-year-old woman with headache.

Authors:  William Jeptha Davenport; Tamara M Pringsheim
Journal:  CMAJ       Date:  2016-10-11       Impact factor: 8.262

3.  Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.

Authors:  T Dorosch; C A Ganzer; M Lin; A Seifan
Journal:  Curr Pain Headache Rep       Date:  2019-09-12

Review 4.  OnabotulinumtoxinA (BOTOX®): a review of its use in the prophylaxis of headaches in adults with chronic migraine.

Authors:  James E Frampton
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

Review 5.  Migraine prophylaxis: what is new and what we need?

Authors:  P Barbanti; C Aurilia; G Egeo; L Fofi
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

Review 6.  Beneficial Extracardiac Effects of Cardiovascular Medications.

Authors:  Asra K Butt; Jay Patel; Hamid Shirwany; Qasim Mirza; Jonathan Hoover; Rami N Khouzam
Journal:  Curr Cardiol Rev       Date:  2022

7.  A prospective, open-label study of milnacipran in the prevention of headache in patients with episodic or chronic migraine.

Authors:  Emily Rubenstein Engel; David Kudrow; Alan M Rapoport
Journal:  Neurol Sci       Date:  2013-09-13       Impact factor: 3.307

8.  A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache.

Authors:  Jeffrey L Jackson; Elizabeth Cogbill; Rafael Santana-Davila; Christina Eldredge; William Collier; Andrew Gradall; Neha Sehgal; Jessica Kuester
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

9.  Comparative efficacy trial of cupping and serkangabin versus conventional therapy of migraine headaches: A randomized, open-label, comparative efficacy trial.

Authors:  Mohammad Dehghani Firoozabadi; Maryam Navabzadeh; Mohammad Khodashenas Roudsari; Mohsen Zahmatkash
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852

10.  The Use of Pharmacological Preventive Therapy for Migraine With Weight Gain Potential Amid Coronavirus Disease 2019 Pandemic.

Authors:  Chia Siang Kow; Syed Shahzad Hasan
Journal:  Headache       Date:  2020-10       Impact factor: 5.311
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.